Venus Remedies Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock, trading in the EQ series, hit its upper circuit price band of 5%, closing at Rs 1,025.75 after opening with a 2.15% gap up. The price band capped the maximum daily gain at 5%, and the stock reached this ceiling, indicating that demand exceeded what the price band could accommodate. The intraday range was relatively narrow, with a low of Rs 965.25 and a high at the circuit price, reflecting the mechanical freeze in trading once the upper limit was reached. This scenario is typical when buyers are willing to pay the ceiling price but sellers are absent, creating unfilled demand — a hallmark of upper circuit events.

Delivery and Volume Analysis

Volume on the circuit day was 0.47 lakh shares, translating to a turnover of approximately Rs 4.75 crore. While total traded volume is often lower on circuit days due to the price lock, the delivery volume data offers deeper insight. On 9 Apr 2026, delivery volume surged by 142.02% compared to the 5-day average, with 85,910 shares taken in delivery. This sharp rise in delivery volume signals genuine buying conviction rather than speculative intraday trading. The fact that shares traded were being taken into investors' demat accounts suggests a longer-term interest in Venus Remedies Ltd — is this delivery surge a sign of sustained momentum or a short-lived spike? The total traded volume being mechanically suppressed by the circuit does not detract from the quality of the move, as delivery volumes are the more telling metric on such days.

Moving Averages and Trend Context

Venus Remedies Ltd is trading comfortably above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment confirms a strong bullish trend preceding the circuit event. The stock has been gaining for three consecutive sessions, accumulating a 12.06% return in that period. The upper circuit on 10 Apr 2026 thus amplifies an already established upward momentum. The trend confirmation from moving averages adds weight to the conviction narrative, but how sustainable is this rally given the micro-cap nature of the stock?

Liquidity and Market Capitalisation Context

With a market capitalisation of Rs 1,330 crore, Venus Remedies Ltd is classified as a micro-cap stock. This segment is known for thinner liquidity and more pronounced price swings, making upper circuit hits more frequent and impactful. The stock's liquidity profile indicates it is liquid enough for a trade size of Rs 0.14 crore based on 2% of the 5-day average traded value. While this suggests some capacity for institutional participation, the limited trade size highlights the liquidity risk inherent in micro-cap stocks. Investors should be mindful that entering or exiting sizeable positions could be challenging due to thin order books and limited market depth.

Intraday Price Action

The intraday price movement on 10 Apr 2026 showed a low of Rs 965.25 and a high at the circuit price of Rs 1,025.75. The stock opened with a gap up of 2.15%, signalling early buying interest. The narrow range near the upper circuit price is typical of such events, where the price is mechanically capped and trading freezes once the ceiling is hit. This pattern reflects the intensity of buying pressure that could not be matched by sellers, reinforcing the unfilled demand scenario. The stock also set a new 52-week and all-time high during the session, underscoring the strength of the move.

Brief Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by steady demand and innovation-driven growth. The company’s recent performance has outpaced its sector, with a 5.14% gain on the day compared to the sector’s 0.15% decline. This relative outperformance adds a layer of fundamental support to the technical momentum observed. However, as a micro-cap, the stock remains sensitive to liquidity and market sentiment shifts.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at a 5% price band capped the stock’s gain at Rs 1,025.75, but the exchange ceiling stopped the rally, not the buyers. The surge in delivery volumes by over 140% against the 5-day average on the previous day indicates that the shares traded were being taken into long-term holdings rather than speculative intraday positions. Coupled with the stock trading above all major moving averages and a three-day consecutive gain streak, the data points to genuine buying momentum. However, the micro-cap status and limited liquidity — with a trade size capacity of just Rs 0.14 crore — introduce a significant liquidity risk. This means that while the circuit move is impressive, investors should be cautious about the challenges of entering or exiting sizeable positions in Venus Remedies Ltd. After a 5.0% single-day gain at upper circuit, is Venus Remedies still worth considering or has the move already happened?

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →